Ignite Creation Date:
2025-12-24 @ 2:04 PM
Ignite Modification Date:
2026-02-23 @ 5:56 PM
Study NCT ID:
NCT02841995
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2016-07-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease
Sponsor:
Kadmon, a Sanofi Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Graft vs Host Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | cGVHD | View |
| None | Allogeneic hematopoietic stem cell transplantation | View |
| None | Immune System Diseases | View |
| None | Steroid refractory chronic graft vs host disease (cGVHD) | View |
| None | Bone Marrow Transplantation | View |
| None | Anti-Inflammatory Agents | View |
| None | Glucocorticoids | View |
| None | Corticosteroids | View |